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RENAL FUNCTION, SODIUM AND 
WATER HOMEOSTASIS IN 
PATIENTS WITH IDIOPATHIC 
EXTRAHEPATIC PORTAL VEIN 
THROMBOSIS COMPARED WITH 
NORMAL HEALTHY CONTROLS 
Brian L Rayner, Simon C Robson, Ralph E Kirsch, 
Michael Voigt 
Objectives. To determine whether portal hypertension in the 
absence of liver disease contributes to changes in renal 
function and renal sodium and water handling. 
Methods. Nine patients with extrahepatic portal vein 
thrombosis (PVT) with normal liver function and histology 
were compared with 9 matched healthy control subjects. All 
underwent standard measurements of glomerular filtration 
rate and effective renal blood flow using inulin and para-
aminohippuric acid (PAH) clearances, respectively_ Sodium 
excretion and renin and aldosterone levels were studied 
before, during and after an intravenous saline infusion, 
Results_ At baseline there were no differences in inulin 
clearance, PAH clearance, fractional excretion of sodium 
and free water excretion. During and after the saline 
infusion both groups showed a significant increase in 
sodium excretion with a reduction in water excretion, while 
the PAH and inulin clearances remained unchanged. 
Although aldosterone and red n levels both fell after the 
infusion, aldosterone levels were significantly lower in the 
PVT group. There were no other significant differences 
between the PVT and control groups. 
Conclusion. Renal function and sodium and water handling 
were comparable in healthy controls and patients with PVT. 
It is unlikely that portal hypertension alone plays a 
significant role in the impaired ability to excrete sodium 
and water in patients with liver cirxhosis-
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Liver cirrhosis is associated with marked abnormalities in the 
systemic circulation and in renal function, which tend to 
increase with time.'·3 In the pre-ascitic phase patients do not 
have abnormalities in renal function, but they may be unable to 
excrete a sodium load or escape the sodium retaining effects of 
mineralocorticoids.'·'.s In the ascitic phase there is sodium 
retention leading to cirrhosis and oedema.' As the cirrhosis 
advances· the renal capacity to excrete sodium worsens, and 
there is renal vasoconstriction, which may culminate in the 
hepatorenal syndrome.' The most important initiating 
pathophysiological event appears to be peripheral arterial 
vasodilatation leading to maldistribution of the blood volume 
and a hyperdynamic circulation.• Nitric oxide, a potent 
endothelium-derived relaxing factor, may be a mediator of 
haemodynarnic abnormalities and sodium and water retention 
in cirrhosis.7 
Chronic portal hypertension results in increased portal 
pressure and reduced splanchnic vascular resistance leading to 
marked splanchnic hyperaemia.• In experiments using animals 
with surgically induced portal hypertension there is enhanced 
production of nitric oxide, .. 11 but this may be less than in 
cirrhotic rats." Portal caval shunting may also be a factor as in 
experimental models using animals with surgically created 
portacaval shunting, there is hyperaldosteronuria and reduced 
ability to excrete a sodium load.13 There are also changes in the 
production of prostaglandins, and a heightened sensitivity to 
the haemodynamic effects of endotoxin. '4.15 These animal 
experiments suggest a possible role for portal hypertension and 
·portal caval shunting in haemodynarnic changes, and sodium 
and water retention seen in cirrhotics. There are no human 
studies examining the effect of portal hypertension in the 
absence of liver disease in the genesis of systemic 
vasodilatation, and the resultant abnormalities in renal function 
and sodium excretion. Patients with idiopathic portal vein 
thrombosis (PVT) have portal hypertension and portal systemic 
shunting in the absence of liver disease. A local cohort of these 
patients has been previously described'6 and extensively 
studied, showing abnormalities in autonomic function, 
haemostasis and immunological function. 17-19 Detailed 
investigation of renal function, sodium and water handling 
have not been previously undertaken. This presented an ideal 
opportunity to test the hypothesis that portal hypertension in 
the absence of cirrhosis may play a role in the genesis of renal 
functional abnormalities and impaired ability to excrete salt 
and water. 
pATIENTS AND SUBJECTS 
Nine patients with PVT were studied, all with a history of 
. variceal bleeding. The patients had previously been extensively 
evaluated.16 This included a liver biopsy, ultrasound and 
computed tomographic scanning, and angiography, which 
consisted of splenic and superior mesenteric artery and venous 
phase filling. The diagnosis of PVT was based on a normal 
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liver biopsy, normal liver function tests, and demonstration of 
obstruction of the portal vein. All patients were followed up 
regularly at the Liver Clinic for ongoing surveillance and 
obliteration of their oesophageal varices. Healthy sex- and age-
matched volunteers were used as control subjects. Informed 
consent was obtained from all subjects and patients, and the 
study was approved by the University of Cape Town Research 
and Ethics Committee. Patients with PVT were excluded from 
the study if their oesophageal varices had not been successfully 
obliterated and / or they had had a variceal bleed in the past 6 
months, or if they had any evidence of concomitant but 
unrelated renal disease. 
M ETHODS 
Estimation of glomerular filtration rate (GFR) and effective 
renal blood flow (ERBF) was carried out as outlined by Duarte 
et a[.2JJ using inulin and para-aminohippuric acid (PAH) 
clearances. Inulin and PAH were supplied by Cypros 
Pharmaceuticals, USA and MSD, South Africa respectively. At 
0 minutes the subjects and patients were given 700 ml of water 
of drink, and a loading dose of inulin (0.5 ml / kg, 10% solution) 
and PAH (0.05 ml / kg, 20% solution) in 50 ml saline was 
administered intravenously. This was followed by a continuous 
infusion of inulin and PAH to maintain stable plasma levels. 
Oral water intake was matched to the urine output until the 
saline infusion was commenced. No food intake was allowed 
for the duration of the study. At 45 minutes the bladder was 
completely emptied, and the estimation of GFR and ERBF was 
commenced under basal conditions. Blood and urine were 
taken at half-hourly intervals for inulin, PAH, sodium and 
creatinine until the completion of the study at 255 minutes. The 
collections were conveniently divided into two 30-minute 
collections before, during, and after the saline infusion. The 
urine volume osmolality was also measured, and the serum 
osmolality was estimated by doubling the serum sodium. 
At 105 minutes blood specimens were taken for renin and 
aldosterone, and 1 litre of normal saline was infused 
intravenously and completed at 165 minutes. The inulin and 
PAH infusion was stopped at 225 minutes, and at 255 minutes 
the final urine and blood specimens (including renin and 
aldosterone) were taken. 
For the purposes of easier analysis, the inulin and PAH 
clearances were averaged for the hour before the saline 
infusion, the hour during, and the hour after. Free water 
clearance was calculated using the formula: Cwater "' V(l -
U05m/P osm), where Vis urine volume, Uosm and P osm are the 
urine and plasma osmolality, and Cwater is the free water 
clearance . 
Inulin was assayed by hydrolysis to fructose, which was then 
reacted with indole-3-acetic acid to form a purple colour, and 
read photometrically. PAH was assayed following diazotisation 
with HN02. The excess HN02 was removed with N-1-napthyl-
ethylenediamine. The mauve colour was read photometrically. 
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Aldosterone and renin were assayed using the Aldosterone 
Maia Kit and the GammaCoat(
25
I] Plasma Renin Activity 
Radioimmunoassay Kit respectively. Urine osmolality was 
determined by comparative measurements of freezing points of 
pure water and urine. Creatinine and sodium were measured 
using Synchron CX Systems. 
Statistical analysis was done with Statistica using the 
repeated measures analysis of variance, with time and group 
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Nine patients and 9 age- and sex-matched controls were 
studied. All patients in the PVT group were of mixed racial 
origin, while in the control group there were 3 whites, 3 blacks 
and 3 patients of mixed racial origin. There were 5 males and 4 
females in each group. The 2 groups were well matched at 
baseline with no significant differences in GFR, ERBF, 
creatinine, aldosterone, renin, free water clearance fractional 
excretion of sodium and sodium excretion (Table I). 
Fig. 1. Changes in mean GFR in the PVT and control groups over 
time. (Please note: In all figures the means of the control and PVT 
groups are separated slightly at the time points for ease of viewing.) 
With the initiation of the saline infusion the GFR and ERBF 
were not sigrtificantly changed during or after COIJlpletion of 
the infusion (Figs 1 and 2). The rate of urinary sodium 
increased significantly during and after the infusion, but again 
did not differ between the two groups (Fig. 3). Free water 
clearance decreased significantly after the saline infusion (Fig. 
4). Serum sodium levels remained fairly constant in both the 
PVT and control groups (not shown) . Not unexpectedly, both 
the aldosterone and renin levels declined appropriately before 
and after the saline infusion . In addition, while the renin levels 
were similar in the two groups, the aldosterone levels were 
significantly lower in the PVT group when compared with 
control equivalent time points (Figs 5 and C). 















105 165 225 
Time (minutes) 
The role of portal hypertension and portal systemic shunting in 
the genesis of sodium and water retention in chronic liver 
Fig. 2. Changes in mean ERBF in the PVT and control groups over 
time. 
Table L Mean baseline paametem md mean diffaenc:es in the PVf and control groups 
Control 
pilralneta" (SEM) PVT (SEM) 
Age (yrs) 35.4 (3.1) 35 (5.3) 
~~~ ~~ v~ 
Sodium (mmol/1) 140.6 (0.79) 139.5 (0.83) 
Creatinine (pmol/1) 71 (4.4) (D (4.1) 
GFR (ml/min/1.73 m') 86.3 (6.83) 94.2 (8.1) 
ERBF (ml/111ia/1.73 m') 572.6 (41.6) 583.6 (73) 
Renin (ng/ml/hr) 0.88 (0.250) 0.72 (0.18) 
Aldosterone (pM) 252 2 (27.7) 214.3 (242) 
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Fig. 3. Changes in mean sodium excretion in the PVT and control 
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Fig. 4. Changes in mean free water clearance in the PVT and control 
groups over time. 
disease has never been fully resolved. Animal experiments 
have suggested a role. In animals with surgically induced 
portal hypertension there is enhanced production of nitric 
oxide; .. 11 it has been suggested that this plays an important 
pathophysiological role in animals and humans with cirrhosis.' 
In one comparative experiment the production of nitric oxide 
was greater in cirrhotic rats compared with those with portal 
hypertension alone, suggesting a l~s important role for portal 
hypertension. 12 In other experimental models using animals 


















Fig. 5. Changes in mean aldosterone levels in the PVT and control 
groups over time. 
......... 
















Fig. 6. Changes in mean renin levels in the PVT and control groups 
over time. 
with surgically created portacaval shunting there was 
hyperaldosteronuria and reduced ability to excrete a sodium 
load.13 Changes in the production of prostaglandins, and a 
heightened sensitivity to the haemodynarnic effects of 
endotoxin, have also been recorded.14· ' 5 In contrast, there have 
been no experiments in humans to address this issue, and our 
patients with PVT without liver disease presented an ideal 
opportunity to test the hypothesis. 
